Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Quantensicherheit! Ist diese Aktie noch völlig unterschätzt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.10.Earnings roundup: Lilly's unwavering momentum, Novartis' rebound and GSK's waiting game
29.10.Labor Department finalizes sweeping PBM disclosure rule
29.10.Genmab soars to record highs after cancer drug succeeds in key trial
29.10.HHS to allow compounders to make 6 unapproved peptides
29.10.Flagship blends three biotech startups to form Etcelera
28.10.Lilly's 'triple-G' drug tops Novo's Ozempic in diabetes trial
28.10.FDA unveils guidance for 'plug and play' gene therapies
28.10.Lilly shuffles business structure; Novartis writes off part of Avidity deal
27.10.Ferring to acquire next-gen IVF startup Gameto for up to $1.4B
27.10.Court rejects Novo bid to block Lilly obesity drug ads
27.10.Artiva to quit autoimmune cell therapy work, cut staff after patient deaths
26.10.Corxel, an obesity drugmaker, to go public via SPAC deal
26.10.BioNTech, DualityBio say ADC had 'modest' benefit in breast cancer study
26.10.ESMO '26: A cancer vaccine debate, Roche's KRAS progress and Amgen's 'unprecedented' data
26.10.Another autoimmune CAR-T death; Treasury zeroes in on China deals
26.10.The molecule was fine. The moment wasn't.
26.10.Novel protein and peptide therapeutics
23.10.This week in charts: a big year for RNAi developers
23.10.Star adds $200M after spinout successes
22.10.Moderna, Merck shares fall on eagerly anticipated cancer vaccine results
22.10.Biohaven's previously rejected rare disease drug to get fresh FDA review
22.10.GLP-1 compounder issues recall for copycat Zepbound
22.10.Roche affirms sales outlook amid doubts about its future
21.10.GSK, Ionis win US approval for first-of-its-kind hepatitis B drug
21.10.Roivant, continuing ascent, claims another victory for rare disease drug